神経血管インターベンションデバイス市場：製品、プロセス、適応症、最終用途別-2025～2030年の世界予測

神経血管インターベンションデバイス市場は、2023年に40億1,000万米ドルと評価され、2024年には42億5,000万米ドルに達すると予測され、CAGR 6.46％で成長し、2030年には62億1,000万米ドルに達すると予測されています。

神経血管インターベンションデバイスは、脳や脊椎の血管に影響を及ぼす神経疾患の診断と治療に使用される重要なツールです。脳卒中や動脈瘤の有病率が上昇するにつれて、これらの機器は、患者の転帰を向上させ回復時間を短縮する低侵襲処置に必要となっています。主要用途には塞栓術、血栓除去術、ステント留置術などがあり、病院、専門クリニック、研究機関などのエンドユーザーにサービスを提供しています。市場成長の主要要因は、技術の進歩、世界人口の高齢化、医療費の増加であり、これらすべてが先進的治療法の採用を後押ししています。アジア太平洋の新興市場は、医療インフラへの投資の増加と患者数の増加により、大きなビジネス機会をもたらしています。しかし、発展途上地域では、機器の高コスト、厳しい規制の枠組み、熟練した専門家の不足といった要因が制約となっています。企業は、医療プロバイダーとの戦略的パートナーシップに注力し、精度と安全性を高めた費用対効果の高い次世代機器を開発するための研究開発に投資すべきです。イノベーションの機会は、先進的データ分析によって促進される個別化された患者ケアとともに、機器の性能と患者の転帰を改善するためのAIとロボティクスの統合にあります。生分解性材料や遠隔モニタリング技術の調査も、将来の進歩に期待が持てる。市場は競合が激しく、既存参入企業と新規参入参入企業の両方が、継続的な製品強化や地域拡大を通じてイノベーションを推進しています。成長を維持するためには、技術動向を常に把握し、コスト懸念に対処し、進化する規制へのコンプライアンスを確保することが重要です。企業は、ビッグデータとリアルタイムのモニタリングを活用して個別化治療を提供し、患者エンゲージメントを向上させる必要があります。技術の進歩と新たな市場の需要を捉えながら、これらの課題に適切に対処することで、企業は神経血管インターベンションデバイス市場の成長機会を効果的に活用することができます。

市場力学：急速に進化する神経血管インターベンションデバイス市場の主要市場洞察を公開

神経血管インターベンションデバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の神経血管疾患の発生率の増加
  • 低侵襲手術への嗜好の高まり
• 市場抑制要因
  • 償還シナリオの欠如と神経血管インターベンションデバイスの製品リコール
• 市場機会
  • 神経血管インターベンションデバイスの技術的進歩
  • 神経血管研究開発と治療センターへの投資の増加
• 市場課題
  • 神経血管インターベンションデバイス操作の技術的限界

ポーターのファイブフォース：神経血管インターベンションデバイス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、神経血管インターベンションデバイス市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：神経血管インターベンションデバイス市場における外部からの影響の把握

外部マクロ環境要因は、神経血管インターベンションデバイス市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：神経血管インターベンションデバイス市場における競合情勢の把握

神経血管インターベンションデバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：神経血管インターベンションデバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、神経血管インターベンションデバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目セグメントを網羅した包括的な市場分析を提供しています。

1.市場の浸透度：産業主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で神経血管疾患の発生率が増加
    • 低侵襲手術への関心が高まる
  • 抑制要因
    • 神経血管インターベンションデバイスの償還シナリオと製品リコールが不足しています
  • 機会
    • 神経血管インターベンションデバイスにおける技術的進歩
    • 神経血管研究開発と治療センターへの投資増加
  • 課題
    • 神経血管インターベンションデバイスの操作に関する技術的制限
• 市場セグメンテーション分析
  • 製品：さまざまな種類の血管内神経外科手術におけるカテーテルの基本的な役割
  • プロセス：脳血管造影における神経血管インターベンションデバイスの利用拡大
  • 適応症：虚血性脳卒中に対する神経血管インターベンションデバイスの利用の急増
  • 最終用途：病院における総合的な設備と専門人材の導入拡大神経血管インターベンションデバイス
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 神経血管インターベンションデバイス市場：製品別

• イントロダクション
• バルーンシステム
• 頸動脈ステント
• カテーテル
• 塞栓コイル
• 塞栓保護デバイス
• フローダイバータ
• ガイドワイヤ
• 頭蓋内ステント
• 嚢内デバイス
• 神経血栓除去装置
  • 吸引装置
  • ステント回収装置
  • 超音波補助装置

第7章 神経血管インターベンションデバイス市場：プロセス別

• イントロダクション
• 頸動脈内膜切除術
• 脳血管造影検査
• コイル巻き
• 流れの転換
• 顕微手術クリッピング
• 神経血栓除去術
• ステント留置

第8章 神経血管インターベンションデバイス市場：適応症別

• イントロダクション
• 動静脈奇形
• 脳動脈瘤
• 虚血性脳卒中
• 狭窄症の治療

第9章 神経血管インターベンションデバイス市場：最終用途別

• イントロダクション
• 外来手術センター
• 病院
• 専門クリニック

第10章 南北アメリカの神経血管インターベンションデバイス市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の神経血管インターベンションデバイス市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの神経血管インターベンションデバイス市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • Baylis Medical Technologies、静脈ステント再疎通を強化するPowerWire Pro RFガイドワイヤを発表
  • S3V Vascular Technologies、神経血管インターベンションのイノベーションのために30億インドルピーの重要なシリーズB資金調達を確保し、エリート投資家の関心を集めている
  • Nanoflex Robotics、神経血管インターベンションのための革新的な遠隔操作システムを導入
  • Zylox-Tonbridge、Avingerと戦略的提携を結び、大中華圏における神経血管インターベンションの革新を推進
  • Philipsが先進のAzurion Neuro Biplaneインターベンションシステムを発表
  • TruCourse技術を搭載したCERENOVUSの画期的な脳卒中インターベンション、CEREGLIDE 71の導入
  • OrbusNeichとAbbottのCSIが米国での独占販売提携を拡大
  • SensomeとAsahi Intecc、AI搭載の先進的なClotild Smart Guidewireで提携
  • Stryker、神経血管インターベンションセグメントでの提供を拡大するため、Cerus Endovascular社を買収
  • Infinity Neuro、インスピラ吸引カテーテルのCEマークを取得

企業一覧

• Abbott Laboratories
• Acandis GmbH
• Asahi Intecc Co., Ltd.
• Balt Group
• Boston Scientific Corporation
• Carl Zeiss AG
• Edwards Lifesciences Corporation
• Evasc Medical Systems Corp.
• GE Healthcare
• Imperative Care Inc.
• Integer Holdings Corporation
• Japan Lifeline Co.
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.
• Lepu Medical Technology（Beijing）Co., Ltd.
• LivaNova PLC
• Medikit Co., Ltd.
• Medtronic PLC
• Merit Medical Systems, Inc.
• Microport Scientific Corporation
• Nanoflex Robotics AG
• NeuroSafe Medical Co., Ltd.
• Penumbra, Inc.
• Phenox GmbH by Wallaby Medical, LLC
• Rapid Medical Ltd.
• Route 92 Medical, Inc.
• Siemens Healthineers AG
• Stryker Corporation
• Terumo Corporation
• Zylox-Tonbridge Medical Technology Co., Ltd.

LIST OF FIGURES

• FIGURE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NEUROVASCULAR INTERVENTION DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BALLOON SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRASACCULAR DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ASPIRATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ULTRASOUND-ASSISTED DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ENDARTERECTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COILING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROSURGICAL CLIPPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANEURYSMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENOSIS TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 55. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 57. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 58. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 82. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 84. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 85. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 87. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 89. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 90. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 91. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 102. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 107. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 109. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 110. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 112. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 114. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 115. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 116. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 117. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 119. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 120. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 121. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 122. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 124. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 125. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 126. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 127. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 129. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 130. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 131. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 132. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 134. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 135. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 136. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 137. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 139. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 140. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 141. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 142. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 143. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 145. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 146. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 147. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 148. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 150. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 151. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 152. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 153. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 155. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 156. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 157. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 158. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 160. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 161. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 162. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 163. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 165. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 166. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 167. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 168. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 170. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 171. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 172. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 173. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 175. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 176. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 177. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 178. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 180. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 181. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 182. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 183. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 185. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 186. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 187. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 188. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 189. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 190. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 191. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 192. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 193. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 195. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 196. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 197. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 198. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 200. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 201. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 202. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 203. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 204. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 205. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 206. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 207. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 208. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 209. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 210. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 211. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 212. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 213. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 215. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 216. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 217. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 218. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 219. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 220. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 221. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 222. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 223. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 225. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 226. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 227. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 228. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 230. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 231. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 232. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 233. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 234. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 235. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 236. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 237. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 238. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 239. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 240. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 241. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 242. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 243. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 244. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 245. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 246. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 247. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 248. NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 249. NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Neurovascular Intervention Devices Market was valued at USD 4.01 billion in 2023, expected to reach USD 4.25 billion in 2024, and is projected to grow at a CAGR of 6.46%, to USD 6.21 billion by 2030.

Neurovascular intervention devices are critical tools used in the diagnosis and treatment of neurological disorders affecting blood vessels in the brain and spine. As the prevalence of strokes and aneurysms rises, these devices have become necessary for minimally invasive procedures that enhance patient outcomes and reduce recovery times. The primary applications include embolization, thrombectomy, and stenting, serving end-users like hospitals, specialized clinics, and research institutions. Market growth is chiefly influenced by technological advancements, an aging global population, and rising health expenditures, all of which encourage the adoption of advanced treatment methods. Emerging markets in Asia-Pacific offer substantial opportunities due to increasing investments in healthcare infrastructure and a growing patient pool. However, factors like the high cost of devices, stringent regulatory frameworks, and a lack of skilled professionals in developing regions pose limitations. Companies should focus on strategic partnerships with healthcare providers and invest in R&D to develop cost-effective, next-generation devices with enhanced precision and safety features. Innovation opportunities lie in the integration of AI and robotics for improved device performance and patient outcomes, along with personalized patient care facilitated by advanced data analytics. Research on biodegradable materials and remote monitoring technologies also holds promise for future advancements. The market is competitive, with both established players and new entrants driving innovation through continuous product enhancements and geographical expansion. Staying attuned to technological trends, addressing cost concerns, and ensuring compliance with evolving regulations are crucial for sustaining growth. Companies should leverage big data and real-time monitoring to provide personalized therapies and improve patient engagement. Adequately addressing these challenges while seizing technological advancements and emerging market demand will position businesses to capitalize on growth opportunities in the neurovascular intervention devices market effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurovascular Intervention Devices Market

The Neurovascular Intervention Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence of neurovascular diseases worldwide
  • Growing preference for minimally invasive procedures
• Market Restraints
  • Lack of reimbursement scenario and product recall for neurovascular intervention devices
• Market Opportunities
  • Technological advancements in neurovascular intervention devices
  • Rising investments in neurovascular R&D and treatment center
• Market Challenges
  • Technical limitations of operating neurovascular intervention devices

Porter's Five Forces: A Strategic Tool for Navigating the Neurovascular Intervention Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurovascular Intervention Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurovascular Intervention Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurovascular Intervention Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurovascular Intervention Devices Market

A detailed market share analysis in the Neurovascular Intervention Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurovascular Intervention Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurovascular Intervention Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Intervention Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Asahi Intecc Co., Ltd., Balt Group, Boston Scientific Corporation, Carl Zeiss AG, Edwards Lifesciences Corporation, Evasc Medical Systems Corp., GE Healthcare, Imperative Care Inc., Integer Holdings Corporation, Japan Lifeline Co., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co., Ltd., LivaNova PLC, Medikit Co., Ltd., Medtronic PLC, Merit Medical Systems, Inc., Microport Scientific Corporation, Nanoflex Robotics AG, NeuroSafe Medical Co., Ltd., Penumbra, Inc., Phenox GmbH by Wallaby Medical, LLC, Rapid Medical Ltd., Route 92 Medical, Inc., Siemens Healthineers AG, Stryker Corporation, Terumo Corporation, and Zylox-Tonbridge Medical Technology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Neurovascular Intervention Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Balloon Systems, Carotid Stents, Catheters, Embolic Coils, Embolic Protection Devices, Flow Diverters, Guidewires, Intracranial Stents, Intrasaccular Devices, and Neurothrombectomy Devices. The Neurothrombectomy Devices is further studied across Aspiration Devices, Stent Retrievers, and Ultrasound-assisted Devices.
• Based on Process, market is studied across Carotid Endarterectomy, Cerebral Angiography, Coiling, Flow Diversion, Microsurgical Clipping, Neurothrombectomy, and Stenting.
• Based on Indication, market is studied across Arteriovenous Malformations, Cerebral Aneurysms, Ischemic Strokes, and Stenosis Treatment.
• Based on End-use, market is studied across Ambulatory Surgical Centers, Hospitals, and Speciality Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of neurovascular diseases worldwide
    • 5.1.1.2. Growing preference for minimally invasive procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of reimbursement scenario and product recall for neurovascular intervention devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in neurovascular intervention devices
    • 5.1.3.2. Rising investments in neurovascular R&D and treatment center
  • 5.1.4. Challenges
    • 5.1.4.1. Technical limitations of operating neurovascular intervention devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Fundamental role of catheters in various types of endovascular neurosurgical procedures
  • 5.2.2. Process: Proliferating utilization of neurovascular intervention devices in cerebral angiography
  • 5.2.3. Indication: Burgeoning utilization of neurovascular intervention devices for ischemic strokes
  • 5.2.4. End-use: Comprehensive facilities and specialized personnel in hospitals expanding the adoption of neurovascular intervention devices
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Neurovascular Intervention Devices Market, by Product

• 6.1. Introduction
• 6.2. Balloon Systems
• 6.3. Carotid Stents
• 6.4. Catheters
• 6.5. Embolic Coils
• 6.6. Embolic Protection Devices
• 6.7. Flow Diverters
• 6.8. Guidewires
• 6.9. Intracranial Stents
• 6.10. Intrasaccular Devices
• 6.11. Neurothrombectomy Devices
  • 6.11.1. Aspiration Devices
  • 6.11.2. Stent Retrievers
  • 6.11.3. Ultrasound-assisted Devices

7. Neurovascular Intervention Devices Market, by Process

• 7.1. Introduction
• 7.2. Carotid Endarterectomy
• 7.3. Cerebral Angiography
• 7.4. Coiling
• 7.5. Flow Diversion
• 7.6. Microsurgical Clipping
• 7.7. Neurothrombectomy
• 7.8. Stenting

8. Neurovascular Intervention Devices Market, by Indication

• 8.1. Introduction
• 8.2. Arteriovenous Malformations
• 8.3. Cerebral Aneurysms
• 8.4. Ischemic Strokes
• 8.5. Stenosis Treatment

9. Neurovascular Intervention Devices Market, by End-use

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Hospitals
• 9.4. Speciality Clinics

10. Americas Neurovascular Intervention Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Neurovascular Intervention Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Neurovascular Intervention Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Baylis Medical Technologies Introduces PowerWire Pro RF Guidewire for Enhanced Venous Stent Recanalization
  • 13.3.2. S3V Vascular Technologies Secures Key Series B Funding of INR 300 Crore for Neurovascular Intervention Innovation, Attracting Elite Investor Interest
  • 13.3.3. Nanoflex Robotics Deployed Revolutionary Remote-Operable System for Neurovascular Interventions
  • 13.3.4. Zylox-Tonbridge Forms Strategic Alliance with Avinger to Innovate Neurovascular Interventions in Greater China
  • 13.3.5. Philips Unveils Advanced Azurion Neuro Biplane Interventional System
  • 13.3.6. Introducing CEREGLIDE 71 a CERENOVUS's Breakthrough in Stroke Intervention with TruCourse Technology
  • 13.3.7. OrbusNeich and Abbott's CSI Extend Exclusive Distribution Partnership in the U.S. through 2027
  • 13.3.8. Sensome and Asahi Intecc Collaborate on Advanced AI-Powered Clotild Smart Guidewire
  • 13.3.9. Stryker's Acquired Cerus Endovascular to Expand its Offering in the Neurovascular Intervention Sector
  • 13.3.10. Infinity Neuro Secures CE Mark for Inspira Aspiration Catheters

Companies Mentioned

• 1. Abbott Laboratories
• 2. Acandis GmbH
• 3. Asahi Intecc Co., Ltd.
• 4. Balt Group
• 5. Boston Scientific Corporation
• 6. Carl Zeiss AG
• 7. Edwards Lifesciences Corporation
• 8. Evasc Medical Systems Corp.
• 9. GE Healthcare
• 10. Imperative Care Inc.
• 11. Integer Holdings Corporation
• 12. Japan Lifeline Co.
• 13. Johnson & Johnson Services, Inc.
• 14. Koninklijke Philips N.V.
• 15. Lepu Medical Technology (Beijing) Co., Ltd.
• 16. LivaNova PLC
• 17. Medikit Co., Ltd.
• 18. Medtronic PLC
• 19. Merit Medical Systems, Inc.
• 20. Microport Scientific Corporation
• 21. Nanoflex Robotics AG
• 22. NeuroSafe Medical Co., Ltd.
• 23. Penumbra, Inc.
• 24. Phenox GmbH by Wallaby Medical, LLC
• 25. Rapid Medical Ltd.
• 26. Route 92 Medical, Inc.
• 27. Siemens Healthineers AG
• 28. Stryker Corporation
• 29. Terumo Corporation
• 30. Zylox-Tonbridge Medical Technology Co., Ltd.